EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting tumor-associated macrophages to reverse antitumor drug resistance

Sheng Li, Jiyao Sheng, Dan Zhang, Hanjiao Qin

Aging · 2024

DOI: 10.18632/aging.205858 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Aging, 2024. Verfasst von Sheng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Tumor-Associated Macrophages, Tumor Microenvironment, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, antitumor drugs show limited clinical outcomes, mainly due to adaptive resistance. Clinical evidence has highlighted the importance of the tumor microenvironment (TME) and tumor-associated macrophages (TAMs) in tumor response to conventional antitumor drugs. Preclinical studies show that TAMs following antitumor agent can be reprogrammed to an immunosuppressive phenotype and proangiogenic activities through different mechanisms, mediating drug resistance and poor prognosis. Potential extrinsic inhibitors targeting TAMs repolarize to an M1-like phenotype or downregulate proangiogenic function, enhancing therapeutic efficacy of anti-tumor therapy. Moreover, pharmacological modulation of macrophages that restore the immune stimulatory characteristics is useful to reshaping the tumor microenvironment, thus further limiting tumor growth. This review aims to introduce macrophage response in tumor therapy and provide a potential therapeutic combination strategy of TAM-targeting immunomodulation with conventional antitumor drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmTumor-Associated MacrophagesTumor MicroenvironmentAntineoplastic AgentsNeoplasmsHumansAnimals

Stichwörter der Autor:innen

cancerdrug resistanceimmunotherapytumor microenvironmenttumor-associated macrophages

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • The Second Hospital of Jilin University, Changchun, China.
  • Department of Hepatobiliary and Pancreatic Surgery, Second Hospital of Jilin University, Changchun, China.
  • Department of Radiotherapy, The Second Hospital of Jilin University, Changchun, China.

Zitieren

APA

Li, S., Sheng, J., Zhang, D., & Qin, H. (2024). Targeting tumor-associated macrophages to reverse antitumor drug resistance. Aging. https://doi.org/10.18632/aging.205858

Vancouver

Li S, Sheng J, Zhang D, Qin H. Targeting tumor-associated macrophages to reverse antitumor drug resistance. Aging. 2024. doi:10.18632/aging.205858

BibTeX
@article{Li2024,
  author = {Li, Sheng and Sheng, Jiyao and Zhang, Dan and Qin, Hanjiao},
  title = {Targeting tumor-associated macrophages to reverse antitumor drug resistance},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205858}
}
Kostenlos starten →